Straits Times Index
3,110.73 +36.47 (+1.19%) Nikkei
32,307.86 -550.45 (-1.68%) Hang Seng
16,334.37 -11.52 (-0.07%) FTSE 100
7,554.47 +40.75 (+0.54%) Bitcoin USD
43,882.14 +155.85 (+0.36%) CMC Crypto 200
914.81 +18.10 (+2.02%)
Carmat (CXT.BE)
| Previous close | 7.54 |
| Open | 7.56 |
| Bid | 6.54 x N/A |
| Ask | 7.14 x N/A |
| Day's range | 6.62 - 7.56 |
| 52-week range | 3.02 - 12.14 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireCARMAT Announces the Opening of Its New Production Facility in Bois-d'Arcy, France
PARIS, December 04, 2023--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aimed at providing a therapeutic alternative for patients suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), today announced the opening of its second production facility ("BDA2") in Bois-d'Arcy, in the immediate vicinity of the Company's first production facility ("BDA1").
Business WireCARMAT Presented Its Progress on the EFICAS Clinical Study at the 36th Journées de La Pitié in Paris
PARIS, October 23, 2023--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aimed at providing a therapeutic alternative for patients suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), announces that it has presented its progress on the EFICAS clinical trial at the 36th "Journées de La Pitié" national conference on heart and lung transplantation and circulatory assistance, organized by the cardi
- Reuters
Air Liquide holds less than 1% of French artificial heartmaker Carmat
Carmat warned late Monday that supply issues meant it would miss its full-year sales target and it could run out of cash by the end of October, sending its shares down 27% on Tuesday. Air Liquide said in response to Reuters questions its Carmat holding is held through its Air Liquide Venture Capital (ALIAD) which was set up in 2013. "ALIAD entered the capital of Carmat in April 2014, in the frame of ALIAD strategy to develop industrial partnerships between technology companies and the Air Liquide Group, in 3 sectors: Climate tech, Healthtech and Digital," the company said.
